| |
| |
|
| Insider
Information: |
Loewen Andrea |
| Relationship: |
SVP, Global Regulatory... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
7.0
|
| Percentage
Gain/Loss : |
0.0%
|
 598.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunic Inc |
IMUX |
|
|
0 |
|
0 |
Premium* |
|
|
Reata Pharmaceuticals Inc |
RETA |
SVP, Global Regulatory... |
2023-09-26 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RETA |
Reata Pharmaceuticals Inc |
SVP, Global Regulatory Affairs |
• – – |
2023-09-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(28,416) |
0 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Global Regulatory Affairs |
• – – |
2023-09-14 |
4 |
S |
$172.03 |
$546,181 |
D/D |
(3,175) |
28,416 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Global Regulatory Affairs |
• – – |
2023-05-16 |
4 |
S |
$81.02 |
$25,359 |
D/D |
(313) |
31,591 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Global Regulatory Affairs |
• – – |
2023-05-15 |
4 |
S |
$84.71 |
$8,725 |
D/D |
(103) |
31,904 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Global Regulatory Affairs |
• – – |
2023-05-12 |
4 |
S |
$86.26 |
$582,267 |
D/D |
(6,750) |
32,007 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Global Regulatory Affairs |
• – – |
2023-03-07 |
4 |
S |
$83.36 |
$1,588,137 |
D/D |
(19,036) |
38,757 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Global Regulatory Affairs |
• – – |
2023-03-07 |
4 |
OE |
$27.32 |
$409,800 |
D/D |
15,000 |
57,793 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Global Regulatory Affairs |
• – – |
2023-03-03 |
4 |
S |
$87.73 |
$140,456 |
D/D |
(1,601) |
42,793 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Global Regulatory Affairs |
• – – |
2023-03-02 |
4 |
S |
$90.61 |
$19,753 |
D/D |
(218) |
44,394 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Global Regulatory Affairs |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
11,756 |
44,612 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Global Regulatory Affairs |
• – – |
2022-02-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
32,856 |
|
% |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
